REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Lyofarm Sp. z o.o. (Poland)

Main Activities: Electronic Shopping and Mail-Order Houses
Secondary Activities: Animal Slaughtering and Processing | All Other Food Manufacturing | Pharmaceutical Preparation Manufacturing | All Other Specialty Food Stores | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Department Stores | All Other Support Services
Full name: Lyofarm Sp. z o.o. Profile Updated: May 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Lyofarm Sp. z o.o is a company that develops supplements using liofilization technology. The company offers collagen tablets, vitamin K capsules, and natural extracts. Their focus is on utilizing natural ingredients and preserving their original properties through liofilization. Founded year, number of employees, target market, and revenue information are not available.

Headquarters
Ul. Turystyczna 11/F
Kielce; Swietokrzyskie; Postal Code: 25-557

Contact Details: Purchase the Lyofarm Sp. z o.o. report to view the information.

Website: http://www.lyofarm.pl

Basic Information
Outstanding Shares:
Purchase the Lyofarm Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Lyofarm Sp. z o.o. report to view the information.
Incorporation Date:
September 04, 2018
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
94%
Company Performance
Financial values in the chart are available after Lyofarm Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-52.63%▼
Total operating revenue
-52.63%▼
Operating profit (EBIT)
-83.2%▼
Net Profit (Loss) for the Period
-83.2%▼
Total assets
9.19%▲
Total equity
-233.47%▼
Operating Profit Margin (ROS)
-173.1%▼
Net Profit Margin
-173.1%▼
Return on Equity (ROE)
-57.43%▼
Quick Ratio
-0.24%▼
Cash Ratio
-0.24%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo